Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Pregabalin NDC 71335-1475 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - lbl713351475

Label - lbl713351475

These are Pregabalin capsules with a capacity of 100mg, produced by a company called NILD. They come in a package of 30 capsules and are only available by prescription. The package bears a National Drug Code (NDC) number of 71335-1475-01. It is important to store the capsules at room temperature between 20°C-25°C (68°F-77°F) and away from children.*

Label - lbl7133514752

Label - lbl7133514752

This text appears to be a comparison between two medications, the one being sold under the name "Pachaged by Bryant Ranck Prepack" and the other being "Lyrica 100mg (CV) Capsule" produced by Laurus Labs Ltd. There is also information on how to store the medication and a warning to keep it out of reach of children. The provided number "08197301523487" may be a product or batch code.*

pregabalinchemistrystructure - pregabalin chem structure

pregabalinchemistrystructure - pregabalin chem structure

pregabalin-equation - pregabalin equation

pregabalin-equation - pregabalin equation

pregabalinfig1 - pregabalin fig 01

pregabalinfig1 - pregabalin fig 01

The text seems to be a chart that shows the percentage of patients who improved, with numbers ranging from 3% to 88%. There is also a line indicating the percentage improvement in pain from the baseline, but the exact value is not given. The last line seems to contain some gibberish characters and does not convey any useful information.*

pregabalinfig2 - pregabalin fig 02

pregabalinfig2 - pregabalin fig 02

This is a table showing the percent improvement in pain from baseline for patients who took Pregabalin 160mg for 3 days. The table shows percentages ranging from 2% to 100%. There is also some unclear text that seems to be unrelated to the table.*

pregabalinfig3 - pregabalin fig 03

pregabalinfig3 - pregabalin fig 03

This appears to be a chart or table with medication dosages and reported improvements in pain. Without context or further information, it is not possible to provide a useful description.*

pregabalinfig4 - pregabalin fig 04

pregabalinfig4 - pregabalin fig 04

pregabalinfig5 - pregabalin fig 05

pregabalinfig5 - pregabalin fig 05

This appears to be a table showing the dosages and improvement in pain for three different treatments: Fregabalin 100 mg three times a day, Pregataiin 80 mg three times a day, and placebo. The table also includes the percentage of patients who improved and the percentage of improvement in pain from baseline.*

pregabalinfig6 - pregabalin fig 06

pregabalinfig6 - pregabalin fig 06

pregabalinfig7 - pregabalin fig 07

pregabalinfig7 - pregabalin fig 07

Not-Available. The given text mainly consists of random characters, numbers, and symbols, and does not form a meaningful description in any language.*

pregabalinfig8 - pregabalin fig 08

pregabalinfig8 - pregabalin fig 08

pregabalinfig9 - pregabalin fig 09

pregabalinfig9 - pregabalin fig 09

This text appears to be a chart or graph with numerical values indicating percentages and a timeline of days. The chart displays the estimated percentage of subjects without LTR (which could stand for "long-term response") for both a drug called "Pregabain" and a placebo over a 12-day period. The percentages range from 0% to 20%. There is not enough context to understand the nature of the study or what these percentages represent specifically.*

pregabalinfig10 - pregabalin fig 10

pregabalinfig10 - pregabalin fig 10

This appears to be a table showing percentages of subjects improved from baseline to week 12 on two different medications: Pregetalin and Placeso. The percentages range from 210 to 240 for an unspecified measurement, and Pregetalin shows a 260% improvement while Placeso shows 100% improvement.*

pregabalinfig11 - pregabalin fig 11

pregabalinfig11 - pregabalin fig 11

The text describes a graph or chart showing the percentage of subjects who improved over the course of 16 weeks after taking either Pregabalin or Placebo. The graph includes various percentage values ranging from 100 to 280, with the x-axis displaying week numbers from 210 to 270. There is no further context or information available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.